REVIEW ON APPLICATION AND FACTOR AFFECTING AND OFFICIAL MONOGRAPHS IN DISSOLUTION PROCESS

Authors

  • Mohammad Zishan Department of Pharmaceutics Integral University Kursi Road Lucknow, India
  • Mohammad Amir Department of Pharmaceutics Integral University Kursi Road Lucknow, India
  • Zeeshan Ahmad Department of Pharmaceutics Integral University Kursi Road Lucknow, India
  • Mohd Wasim Hussain Department of Pharmaceutics Integral University Kursi Road Lucknow, India
  • Prashant Singh Department of Pharmacology Integral University Kursi Road Lucknow, India
  • Sahar Idris Department of Pharmacology Integral University Kursi Road Lucknow, India

Abstract

Dissolution testing is a critical methodology which is widely utilized in the development of a new pharmaceutical product. The test, in its simplest form, consists of placing the formulation in a dissolution apparatus containing suitable dissolution medium, allowing it to dissolve over a specified period of time and then assaying the resultant solution using appropriate analytical method to determine the amount of drug. Dissolution tests are relevant for an array of investigations like drug degradation profiles, stability and shelf life studies, physical and mechanical testing of dosage forms, incoming QC testing on raw materials etc. The present review outlines the recent findings on various dissolution apparatuses, their modifications, methods for degassing of media like Helium sparging, Heating and filtering, Vacuum degassing, sonication and dissolution testing of various dosage forms like Immediate Release (IR) Dosage forms, Delayed Release Dosage Forms, Extended Release Dosage Forms, Transdermal Delivery Systems, Powders, Chewable Tablets, Buccal Tablets, Chewing Gums, Soft Gelatin Capsule , Aerosols, Suppositories and other Semisolids.

Keywords: Dissolution , Factor affecting dissolution , Dissolution apparatus

DOI

https://doi.org/10.22270/jddt.v7i3.1422

Author Biographies

Mohammad Zishan, Department of Pharmaceutics Integral University Kursi Road Lucknow, India

Department of Pharmaceutics Integral University Kursi Road Lucknow, India

Mohammad Amir, Department of Pharmaceutics Integral University Kursi Road Lucknow, India

Department of Pharmaceutics Integral University Kursi Road Lucknow, India

Zeeshan Ahmad, Department of Pharmaceutics Integral University Kursi Road Lucknow, India

Department of Pharmaceutics Integral University Kursi Road Lucknow, India

Mohd Wasim Hussain, Department of Pharmaceutics Integral University Kursi Road Lucknow, India

Department of Pharmaceutics Integral University Kursi Road Lucknow, India

Prashant Singh, Department of Pharmacology Integral University Kursi Road Lucknow, India

Department of Pharmacology Integral University Kursi Road Lucknow, India

Sahar Idris, Department of Pharmacology Integral University Kursi Road Lucknow, India

Department of Pharmacology Integral University Kursi Road Lucknow, India

References

Brahmankar DM, Jaiswal SB. Biopharmaceutical and pharmacokinetics A treatise Vallaabh Prakashan, First edition, New Delhi 1995, pp 18-50.

Kushwaha P, Handbook of pharmaceuticak technology,first edition published by jaypee brothers Medical publishers (P) Ltd.2015,pp 60-72.

Gray VA, Brown CK, Dressman JB, Leeson LJ, A New General Information Chapter on Dissolution. Pharm. Forum 2001, 27 (6), 3432–3439.

Ross MSF, Rasis M, Mega Paddle,A Recommendation to Modify Apparatus Used in the USP General Test for Dissolution 711 . Pharm. Forum 1998, 24 (3), 6351–6359.

Howard C, Lloyd V, Allen J, Nicholas G, Popovich, Pharmaceutical Dosage Forms and Drug Delivery Systems. Baltimore,Maryland: Lippincott Williams & Wilkins, 7th edition, 1999,

Reeta Rani Thakur, Sonia Narwal. Orally disintegrating preparations, recent advancement in formulation and technology. Journal of Drug Delivery & Therapeutics, 2012, 2(3), 87-96.

Jayaprakash S, Mathew Ebin P Sovichan, Lalithcherian, Rani S, Praveen Raj R. Study on the effects of various disintegrants dispersible tablets. International Research Journal of Pharmacy, 2012, 3(5), 146-152.

United States Pharmacopeial Convention, Inc. United States Pharmacopeia 26. Rockville,Maryland: United States Pharmacopeial Convention, Inc. 2003.

Qureshi SA. The USP Dissolution Apparatus Suitability Test.†Drug Information Journal. 1996; 30;1055-1061.

Desai D, Wang J, Wen H , Li X Timmins P. Formulation design, challenges, and development considerations for fixed dose combination (FDC) of oral solid dosage forms. Pharmaceutical Development and Technology, 2013, 18(6), 1265-1276.

Gupta AK, Arshad S, Poulter NR, Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents, a meta-analysis. Hypertension, 2010, 55(2), 399–407.

Akazawa M, Fukuoka K. Economic impact of switching to fixed-dose combination therapy for Japanese hypertensive patients, a retrospective cost analysis. a BMC Health Services Research, 2013, 124.

World Health Organization. WHO Expert Committee on Malaria (1998, Geneva, Switzerland). WHO expert committee on malaria, twentieth report. World Health Organization Technical Report Series, 2000, 892.

Published

2017-05-14
Statistics
Abstract Display: 927
PDF Downloads: 1156

How to Cite

1.
Zishan M, Amir M, Ahmad Z, Hussain MW, Singh P, Idris S. REVIEW ON APPLICATION AND FACTOR AFFECTING AND OFFICIAL MONOGRAPHS IN DISSOLUTION PROCESS. J. Drug Delivery Ther. [Internet]. 2017 May 14 [cited 2026 Jan. 18];7(3):19-27. Available from: https://www.jddtonline.info/index.php/jddt/article/view/1422

How to Cite

1.
Zishan M, Amir M, Ahmad Z, Hussain MW, Singh P, Idris S. REVIEW ON APPLICATION AND FACTOR AFFECTING AND OFFICIAL MONOGRAPHS IN DISSOLUTION PROCESS. J. Drug Delivery Ther. [Internet]. 2017 May 14 [cited 2026 Jan. 18];7(3):19-27. Available from: https://www.jddtonline.info/index.php/jddt/article/view/1422